Joint Programmes Sample Clauses

Joint Programmes. 52. In line with the Joint Declaration on co-operation and partnership between the Council of Europe and the European Commission signed on 3 April 2001, ongoing co-operation will be reinforced in the framework of the joint programmes, which could include regional thematic programmes. The Council of Europe will continue to provide for consultations with Council of Europe beneficiary member countries. Consultations involving the European Commission, the Secretariat of the Council of Europe and as a general rule the Council of Europe member countries concerned will continue to be organised to discuss the priorities of co- operation. Member and observer states which are donors will be invited to take part in this co-operation and its evaluation.
Sample 1Sample 2
AutoNDA by SimpleDocs
Joint Programmes. ALL MODELS: This Partnership Contract permits the Partner Institution to deliver Franchised, Validated or Joint Programmes subject to the Validation procedures outlined in the LQEH. OR FRANCHISE ONLY: This Partnership Contract permits the Partner Institution to deliver Franchised Programmes only, subject to the Validation procedures outlined in the LQEH. Permission to deliver Validated and/or Joint Programmes must be sought from the University. The Partnership Contract is comprised of the following Contract Documents and to any agreed variation in writing of the Contract Documents signed by each of the parties as a variation: Partnership Agreement This Partnership Agreement setting out the general terms of the Partnership Contract. These general terms are deemed incorporated into each Memorandum of Co-operation and Financial Agreement that the Parties enter into during the Partnership Contract Term. Memorandum of Co-operation A Memorandum of Co-operation signed by the relevant authorised signatories of the University and the Partner Institution specifying the Programme details and other conditions relevant to the delivery of the Programme. The Memorandum of Co-operation will specify the type of Programme to which it will apply.
Sample 1
Joint Programmes. The Parties may, through special arrangements, decide to act jointly in the implementation of any programme or activity in the areas of common interest. The special arrangements will, in each case, define the modalities of participation, roles and responsibilities of each Party, including their respective contributions to the costs, if any, of any programme or activity to be undertaken in accordance with such special arrangements subject to the Parties' respective policies and procedures.
Sample 1
Joint Programmes. To evolve and support certain joint programmes focusing on multi-sectoral area based approach to rural/regional development in cooperation with multiple State & Central Institutions, NGOs and field agencies. These locations should be so identified that S&T intervention could significantly improve the existing socio-economic conditions.
Sample 1
Joint Programmes. „ collaboration on the training of students through joint academic programmes; the co-supervision of doctoral theses.
Sample 1

Related to Joint Programmes

  • Develop programs 1) The Employer will develop and implement health promotion and health education programs, subject to the availability of resources. Each Appointing Authority will develop a health promotion and health education program consistent with the Minnesota Management & Budget policy. Upon request of any exclusive representative in an agency, the Appointing Authority shall jointly meet and confer with the exclusive representative(s) and may include other interested exclusive representatives. Agenda items shall include but are not limited to smoking cessation, weight loss, stress management, health education/self-care, and education on related benefits provided through the health plan administrators serving state employees.

  • Teams One team for the purposes of the Event shall consist of one Vehicle. Each Vehicle can contain a maximum of three Team Members, provided such Team Members have entered into a Team Entry Agreement with the Company or have otherwise agreed in writing to participate in the Event upon and subject to the Terms of Entry and the Event Rules. For the avoidance of doubt, it is the sole responsibility of each Team to inform themselves of the maximum numbers of persons legally permitted to travel in the Vehicle under Relevant Law. Vehicles: Rickshaws The Company shall provide each Team with the contact details of the Approved Hirer who will be able to provide each Team with a Vehicle for use in the Event, subject to the Team entering into an agreement (the “Borrowing Agreementâ€) with the Hirer outlining the terms of use of the Vehicle. Should the Vehicle not be delivered to the Designated Finish Point up to 3 days after the date of the official Finish Line Party, then the team will be liable for either the cost to retrieve the Vehicle and/or the "Hire Costs" beyond this date. Each Vehicle will be of a similar specification to that outlined in Schedule 4 to the Team Entry Agreement. For the avoidance of doubt, the Company shall make no representations or warranties as to the suitability of the Approved Hirer or of the Vehicle for participation in the Event and any rights or warranties which a Team may have or be granted in relation to the Vehicle shall be limited to those contained in the Rental Agreement or implied by any Relevant Law.

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development Plans 4.3.1 For each Licensed Indication and corresponding Licensed Product in the Field, Licensee will prepare and deliver to Licensor a development plan and budget (each a “Development Plan”). The initial Development Plans for each Licensed Indication will be delivered within […***…] after the Grant Date for such Licensed Indication.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!